Abstract:Background Previously, we discovered that human solid tumours, but not normal human tissues, preferentially overexpress interleukin‐13Receptor alpha2, a high binding receptor for IL‐13. To develop novel anti‐cancer approaches, we constructed a chimeric antigen receptor construct using a high binding and codon optimised scFv‐IL‐13Rα2 fragment fused with CD3ζ and co‐stimulatory cytoplasmic domains of CD28 and 4‐1BB. Methods We developed a scFv clone, designated 14‐1, by biopanning the bound scFv phages using huIL‐13Rα2Fc chimeric protein and compared its binding with our previously published clone 4‐1. We performed bioinformatic analyses for complementary determining regions (CDR) framework and residue analyses of the light and heavy chains. This construct was packaged with helper plasmids to produce CAR‐lentivirus and transduced human Jurkat T or activated T cells from peripheral blood mononuclear cells (PBMCs) to produce CAR‐T cells and tested for their quality attributes in vitro and in vivo. Serum enzymes including body weight from non‐tumour bearing mice were tested for assessing general toxicity of CAR‐T cells. Results The binding of 14‐1 clone is to IL‐13Rα2Fc‐chimeric protein is ∼5 times higher than our previous clone 4‐1. The 14‐1‐CAR‐T cells grew exponentially in the presence of cytokines and maintained phenotype and biological attributes such as cell viability, potency, migration and T cell activation. Clone 14‐1 migrated to IL‐13Rα2Fc and cell free supernatants only from IL‐13Rα2+ve confluent glioma tumour cells in a chemotaxis assay. scFv‐IL‐13Rα2‐CAR‐T cells specifically killed IL‐13Rα2+ve but not IL‐13Rα2‐ve tumour cells in vitro and selectively caused significant release of IFN‐γ only from IL‐13Rα2+ve co‐cultures. These CAR‐T cells regressed IL‐13Rα2+ve glioma xenografts in vivo without any general toxicity. In contrast, the IL‐13Rα2 gene knocked‐down U251 and U87 xenografts failed to respond to the CAR‐T therapy. Conclusion Taken together, we conclude that the novel scFv‐IL‐13Rα2 CAR‐T cell therapy may offer an effective therapeutic option after designing a careful pre‐clinical and clinical study.

cDNA clone, prokaryotic expression and purification of human interleukin-13 receptor [alpha]2 chain

Killing Effect Of Interleukin-13 Receptor Alpha 2 (Il-13r Alpha 2) Sensitized Dc-Ctl Cells On Human Glioblastoma U-251 Cells

Killing effect of interleukin-13 receptor alpha 2 (IL-13Ralpha2) sensitized DC-CTL cells on human glioblastoma U251 cells

Expression of Interleukin-13 Receptor Alpha 2 in Brainstem Gliomas

IL13RA2 is overexpressed in malignant gliomas and related to clinical outcome of patients

Molecular Cloning of Human IL-7cDNA and Construction of Eukaryotic Vector Expressing Hil-7

Identification and characterisation of novel CAR‐T cells to target IL13Rα2 positive human glioma in vitro and in vivo

Induction of cytotoxic T lymphocytes specific to malignant glioma using T2 cells pulsed with HLA-A2-restricted interleukin-13 receptor α2 peptide in vitro

Codon Optimization, Expression, Purification, and Functional Characterization of Recombinant Human IL-25 in Pichia Pastoris

Expression, refolding and purification of a human interleukin-17A variant

Expression, purification, and biological characterization of recombinant human interleukin-31 protein

Gene cloning and prokaryotic expression of recombinant human interleukin-18

Isolation of One Novel Full-Length Gene PPIL-3 Related to Human Glioma and Characterization of This Protein

Generation of allo-restricted cytotoxic T lymphocytes against malignant glioma by artificial antigen-presenting cells.

[Prokaryotic expression, purification, refolding and biological assays of recombinant human interleukin 4 inclusion body]

Expression and Purification of Tag-removed Human IL37 by Digestion on Beads in Escherichia Coli.

[Cloning, Expression and Purification of Human TNF-related Apoptosis-Inducing Ligand in Escherichia Coli].

Isolation of one novel full-length gene related to human giioma and its expression in vitro

Expression of Wild-Type and Mutant Interleukin-13 in E.coli and Analysis of the Biological Activity

[Expression and Characterizations of a Novel Full-Length Gene PKIbeta Related to Human Glioma].

HLA Tetramer–Based Artificial Antigen-Presenting Cells Efficiently Stimulate CTLs Specific for Malignant Glioma